MedTrace Logo

Chordate System S020 Acute Migraine Clinical Investigation

NCT02185703 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2015-08-05

No results posted yet for this study

Summary

The main purpose of the study is to evaluate the impact of treatment with the Chordate System S020 (medical device) on acute migraine headache pain.

Conditions

  • Acute Migraine

Interventions

DEVICE

Chordate System S020 in treatment mode

DEVICE

Chordate System S020 in placebo mode

Sponsors & Collaborators

  • Chordate Medical

    lead INDUSTRY

Principal Investigators

  • Hans-Christoph Diener, Prof. Dr. · Universitätsklinikum Essen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02185703 on ClinicalTrials.gov